Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Drotaverine Hydrochloride Injection

Approval Number

国药准字H20253456

Company成都倍特药业股份有限公司

Registration Date

February 25, 2025

Drug Information

Generic Name

盐酸屈他维林注射液

Dosage Form

注射剂

Strength

2ml：40mg（以C₂₄H₃₁NO₄·HCl计）

Drug Type

化学药品

Registration Date

February 25, 2025

Company Information

Applicant Company

Company Name成都倍特药业股份有限公司

Company Address

成都高新区和祥三街263号

Manufacturing Company

Company Name成都倍特药业股份有限公司

Company Address

成都市双流西南航空港经济开发区空港四路1166号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸屈他维林注射液 - NMPA 批准文号 | MedPath